A global medical device company awarded its highest honor to the Urology Department at Horizon Health. Axonics presented its ...

Urinary incontinence, constipation, or a feeling of pain/heaviness in your pelvic area are issues that some women may be ...

AXNX's R20 rechargeable SNM system, offering long-lasting treatment for bladder and bowel dysfunction, gains approval in Australia.

Stool Management System Market is projected to expand at a CAGR of 3.0%, reaching an estimated USD 631.64 million by 2034.

Axonics announced today that it received regulatory approval in Australia for its R20 rechargeable sacral neuromodulation ...

Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics R20® rechargeable sacral neuromodulation ...

The incontinence skincare products market is on a steady growth trajectory, estimated to be valued at USD 2.93 billion in ...

Urology Week 2024, which closes out Urology Awareness Month, is a good time to highlight the innovations in this space.

Bladder problems that can lead to bladder pain are more common in women than in men Herersquo;s what causes them and ways to manage pain ...

Fecal incontinence is a common problem in women, which often enforces life changes owing to embarrassment and social stigma. It is frequently not reported or diagnosed. Age, obstetric trauma ...